What is Rybelsus 7 mg?
Rybelsus 7 mg is an oral prescription medicine containing semaglutide, which belongs to the class of GLP-1 receptor agonists. It is used to help control type 2 diabetes mellitus in adults.
Rybelsus 7 mg is an oral tablet used for managing type 2 diabetes mellitus. It belongs to the class of drugs called GLP-1 receptor agonists (Glucagon-Like Peptide-1).
Unlike most GLP-1 medications that require injection, Rybelsus is the first pill version.
Active Ingredient
Semaglutide (7 mg)
Overview of Rybelsus 7 mg
Generic Name: Semaglutide
Brand Name: Rybelsus
Formulation: Oral tablet
How It Works
Rybelsus 7 helps to:
Increase insulin release when blood sugar is high
Reduce glucose production by the liver
Slow stomach emptying, which helps control appetite and weight
Indications
Uses
Controls blood sugar levels in adults with type 2 diabetes
Helps in weight management (secondary benefit)
Reduces the risk of diabetes-related complications (e.g., kidney or heart issues when combined with proper care)
Dosing
Usually started with 3 mg once daily (for 30 days)
Then increased to 7 mg once daily
If needed, may be further increased to 14 mg once daily
Benefits
Important Notes
Take it once daily on an empty stomach with a small sip of water (≤ 4 ounces)
Wait at least 30 minutes before eating or drinking anything else
Not for type 1 diabetes or diabetic ketoacidosis
Not typically the first-line treatment (usually given if metformin isn’t enough)
Possible Side Effects
Common side effects include:
Serious side effects may include:
Quick Summary Table
Feature | Details |
---|---|
Medicine Type | Oral GLP-1 receptor agonist |
Strength | 7 mg tablet |
Used For | Type 2 Diabetes |
Main Benefit | Lowers blood sugar, helps with weight control |
Dosing | Once daily, empty stomach |
Not For | Type 1 Diabetes, ketoacidosis |
Common Side Effects | Nausea, stomach upset, diarrhea |